TBD Pharmatech, formerly known as TBD-Biodiscovery, is a contract development and manufacturing organisation (CDMO) based in Estonia, EU. The company specializes in the development and production of small molecules, including Active Pharmaceutical Ingredients (APIs), advanced intermediates, and fine chemicals. Since its inception, TBD Pharmatech has been committed to maintaining high-quality standards, achieving GMP compliance since 2008 and holding an ISO 9001:2015 certification. With an emphasis on providing custom solutions tailored to client requirements, TBD can handle batch scales ranging from grams to 150 kilograms. Currently, TBD is welcoming partnership projects into its new EU-based GMP facility, which is slated to launch in 2025.

Services include:
- Contract Development and Manufacturing (CDMO)
- Intermediates
- Fine Chemicals
- APIs (Active Pharmaceutical Ingredients)
- Medical Devices
- Analytical Services
- Animal Health
- cGMP Synthesis
- Contract Manufacturing (CMO)
- Excipients
- Manufacturing
- High Potency
- Cytotoxic & High Potency Compounds

TBD Pharmatech is dedicated to delivering innovative solutions and exceptional quality in the pharmaceutical industry. For more information, visit tbdpharmatech.com.